Subcapsular hematoma of the liver and pylethrombosis in the setting of cholestatic liver injury

Sakamoto, Hirofumi; Suga, Mitsuo; Ozeki, Itaru; Kobayashi, Toshihisa; Sugaya, Toshiaki; Sasaki, Yasushi; Azuma, Nagao; Itoh, Fumio; Sakamoto, Shinichi; Yachi, Akira; Imai, Kohzoh

doi:10.1007/bf02358619

Cited by 8 publications

(5 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The present case had severe cholestasis associated with toxic hepatitis, but no underlying chronic liver disease [3, 7]. …”

Section: Discussionmentioning

confidence: 99%

Successful Hemostasis with Recombinant Activated Factor VII in a Patient with Massive Hepatic Subcapsular Hematoma

Chae¹,

Seo²,

Jeon³

et al. 2009

Case Rep Gastroenterol

View full text Add to dashboard Cite

Recombinant activated coagulation factor VII (rFVIIa) is known to be effective in the management of acquired deficiencies of factor VII and platelet function defects. But recently, rFVIIa has been successfully used to treat ongoing bleeding in disseminated intravascular coagulopathy (DIC) condition. The patient reported here was suspected to be suffering from toxic hepatitis on admission. After percutaneous liver biopsy, bleeding occurred and did not stop even after right hepatic artery embolization. The patient developed a severe hemorrhage that resulted in hypovolemic shock, hemoperitoneum, and a massive subcapsular hematoma. The patient then developed DIC due to massive transfusion, as well as acute liver necrosis. The patient was given 400 μg/kg of rFVIIa. Recombinant factor VIIa was administered in an attempt to control the bleeding. This stabilized the hemoglobin levels of the patient. The patient gradually recovered in 4 months. In conclusion, this case suggests that rFVIIa can be successfully used for the hemostasis of uncontrolled bleeding in DIC.

show abstract

“…The present case had severe cholestasis associated with toxic hepatitis, but no underlying chronic liver disease [3, 7]. …”

Section: Discussionmentioning

confidence: 99%

Successful Hemostasis with Recombinant Activated Factor VII in a Patient with Massive Hepatic Subcapsular Hematoma

Chae¹,

Seo²,

Jeon³

et al. 2009

Case Rep Gastroenterol

View full text Add to dashboard Cite

show abstract

“…EMR is the easier and less time-consuming technique; however, it can only be applied with smaller lesions, usually up to 10 mm in diameter, in order to maximize the probability of "en-bloc" curative resection. Seldomly, this technique can lead to serious complications, such as perforation [20][21][22]. Cap-assisted EMR has also been employed for small esophageal GCTs [7].…”

Section: Discussionmentioning

confidence: 99%

Gastrointestinal Granular Cell Tumor: The First Report of a Multifocal and Potentially Hereditary Case

Sigon,

Fusaro,

Monica

et al. 2024

Gastroenterology Insights

View full text Add to dashboard Cite

Granular cell tumors (GCTs), also known as Abrikossoff tumors, are rare tumors that originate from Schwann cells that primarily localize in the tongue, skin and submucosal tissues and involve the gastrointestinal tract in 11% of cases. We present a case of a young woman who first presented to our center in 2018 for an EGDS to assess a thickening of the esophageal wall, seen on a CT. On that occasion, a diagnosis of Abrikossoff tumor was made. She underwent endoscopic resection with subsequent yearly follow-up without evidence of recurrence. Five years later, during a routine colonoscopy, we found numerous white submucosal formations in all of the explored tracts, with a histological examination compatible with GCTs. Her daughter presented with a white nodule on her tongue, also diagnosed as a GCT. Her daughter was also diagnosed with a GCT of the tongue a few months later. Our research represents a significant contribution to the field given that it presents the first documented case of a patient with multifocal gastrointestinal GCTs and suggests a potential hereditary component.

show abstract

“…EMR is the easier and less time-consuming technique, however, it can be applied only in smaller lesions, usually up to 10 mm in diameter, in order to maximize the probability of "en-bloc" curative resection. Seldomly, this technique can lead to serious complications, such as perforation (20)(21)(22). Cap-assisted EMR has also been employed for small esophageal GCTs (23).…”

Section: Discussionmentioning

confidence: 99%

Gastrointestinal Granular Cell Tumor: The First Report of a Multifocal and Potentially Hereditary Case

Sigon,

Fusaro,

Monica

et al. 2023

Preprint

View full text Add to dashboard Cite

Granular cell tumors (GCTs), known also as Abrikossoff tumors, are rare tumors that originates from Schwann cells that primarily localize in the tongue, skin, and submucosal tissues and involve the gastrointestinal tract in 11% of cases. We present a case of a young woman who first presented to our centre in 2018, for an EGDS to assess a thickening of the esophageal wall, seen on a CT. In that occasion, a diagnosis of Abrikossoff tumor was made. She underwent endoscopic resection with subsequent yearly follow-up without evidence of recurrence. 5 Years later, on a routine colonoscopy, we found numerous white submucosal formations in all of the explored tracts, with a histological examination compatible with GCT. Her daughter presented with a white nodule on her tongue, also diagnosed as GCT. Her daughter was also diagnosed with GCT of the tongue a few months later.

show abstract

Subcapsular hematoma of the liver and pylethrombosis in the setting of cholestatic liver injury

Cited by 8 publications

References 15 publications

Successful Hemostasis with Recombinant Activated Factor VII in a Patient with Massive Hepatic Subcapsular Hematoma

Successful Hemostasis with Recombinant Activated Factor VII in a Patient with Massive Hepatic Subcapsular Hematoma

Gastrointestinal Granular Cell Tumor: The First Report of a Multifocal and Potentially Hereditary Case

Gastrointestinal Granular Cell Tumor: The First Report of a Multifocal and Potentially Hereditary Case

Contact Info

Product

Resources

About